Last reviewed · How we verify

Infusion of hCT-MSC

Joanne Kurtzberg, MD · Phase 1 active Biologic

Infusion of hCT-MSC is a Biologic drug developed by Joanne Kurtzberg, MD. It is currently in Phase 1 development.

At a glance

Generic nameInfusion of hCT-MSC
SponsorJoanne Kurtzberg, MD
ModalityBiologic
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Infusion of hCT-MSC

What is Infusion of hCT-MSC?

Infusion of hCT-MSC is a Biologic drug developed by Joanne Kurtzberg, MD.

Who makes Infusion of hCT-MSC?

Infusion of hCT-MSC is developed by Joanne Kurtzberg, MD (see full Joanne Kurtzberg, MD pipeline at /company/joanne-kurtzberg-md).

What development phase is Infusion of hCT-MSC in?

Infusion of hCT-MSC is in Phase 1.

Related